9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma

Stopped Backbone chemo regimen of gemzar/abraxane no longer most favorable treatment for pancreatic cancer patients.

Conditions

• Pancreatic Adenocarcinoma

Interventions

• DRUG: 9-ING-41
• DRUG: Retifanlimab
• DRUG: Gemcitabine
• DRUG: Abraxane

Sponsor

Anwaar Saeed

Collaborators

• [object Object]
• [object Object]